Clin2
NCT07169799Possibly a fitRecruiting

Freezing spray for GAVE stomach bleeding

Gastric Antral Vascular Ectasia

Part of Digestive system, Heart & circulation clinical trials.

This study tests a freezing spray (Tru-Freeze) to treat GAVE, a condition that causes stomach bleeding. It may help people who need blood transfusions because of GAVE and have had few or no prior endoscopic treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older.
  • You have a confirmed diagnosis of GAVE (a type of stomach blood vessel problem) that mainly affects the antrum (lower part of the stomach).
  • You have needed at least one blood transfusion in the last 6 months because of bleeding from GAVE.
  • You have had either no prior endoscopic treatment for GAVE, or no more than 3 sessions.
  • You have not had a cryoballoon ablation (freezing treatment) for GAVE before.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06306963Recruiting
Stomach blood vessel condition and digestion symptoms study

This study looks at people with a stomach condition called gastric antral vascular ectasia (GAVE) to understand how it affects digestion and causes symptoms. Researchers want to learn if stomach muscle function problems are common in this condition.

Rochester, Minnesota
NCT06772480Not yet recruiting
Thalidomide vs argon plasma coagulation for stomach bleeding in cirrhosis

This trial compares two treatments for anemia caused by GAVE, a condition with bleeding stomach blood vessels. It tests a medication (thalidomide) against a procedure (argon plasma coagulation) to see which is better at improving anemia in people with cirrhosis.

New Delhi, National Capital Territory of Delhi
NCT06830317Not yet recruiting
Endoscopic radiofrequency to reduce blood transfusions in GAVE

This trial tests a treatment called endoscopic radiofrequency, which uses heat to stop bleeding from abnormal blood vessels in the stomach (a condition called GAVE). It aims to reduce the need for blood transfusions and improve anemia.

NCT06759233Not yet recruiting· Phase 2
Freezing plus immunotherapy for advanced stomach cancer

This trial tests a new approach that combines freezing the tumor from inside the stomach with an immunotherapy drug that helps your immune system fight cancer. It is for people with advanced stomach cancer that has not responded to previous chemotherapy.

Shanghai
NCT07749300Not yet recruiting· Phase 2/Phase 3
Medicine to improve stomach view during bleeding emergency

This trial tests whether a medicine called trimebutine maleate helps doctors see the stomach lining more clearly during an emergency endoscopy for upper GI bleeding. If it works, it could help doctors find and treat the bleeding more easily.

NCT06886880Not yet recruiting
Endoscopic treatment for upper digestive bleeding

This trial studies a procedure called endoscopic treatment to stop bleeding in the upper digestive tract. It may help stop active bleeding and reduce the chance of bleeding again.

Hear when a new Gastric Antral Vascular Ectasia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.